China
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 25.08 B
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
2 |
USD 10.87 B
|
Dec. 31, 2023 | USD 1.58 | 1.46% |
|
China |
|
3 |
USD 6.15 B
|
Dec. 31, 2023 | USD 0.53 | 1.44% |
|
China |
|
4 |
USD 5.06 B
|
Dec. 31, 2023 | USD 0.70 | 2.41% |
|
China |
|
5 |
USD 4.14 B
|
Dec. 31, 2023 | USD 0.67 | 1.67% |
|
China |
|
6 |
USD 3.81 B
|
Dec. 31, 2023 | USD 3.45 | 3.36% |
|
China |
|
7 |
USD 2.85 B
|
Dec. 31, 2023 | USD 3.66 | 2.21% |
|
China |
|
8 |
USD 2.76 B
|
Dec. 31, 2023 | USD 2.27 | 3.13% |
|
China |
|
9 |
USD 2.63 B
|
Dec. 31, 2023 | USD 0.34 | 2.88% |
|
China |
|
10 |
USD 2.38 B
|
Dec. 31, 2023 | USD 1.47 | 2.19% |
|
China |
|
11 |
USD 2.28 B
|
Dec. 31, 2023 | USD 0.65 | 2.15% |
|
China |
|
12 |
USD 1.81 B
|
Dec. 31, 2023 | USD 4.26 | 1.90% |
|
China |
|
13 |
USD 1.76 B
|
Dec. 31, 2023 | USD 0.25 | 2.80% |
|
China |
|
14 |
USD 1.66 B
|
Dec. 31, 2023 | USD 7.83 | 2.23% |
|
China |
|
15 |
USD 1.56 B
|
Dec. 31, 2023 | USD 2.34 | 2.64% |
|
China |
|
16 |
USD 1.50 B
|
Dec. 31, 2023 | USD 0.56 | 0.44% |
|
China |
|
17 |
USD 1.36 B
|
Dec. 31, 2023 | USD 1.68 | 2.25% |
|
China |
|
18 |
USD 1.35 B
|
Dec. 31, 2023 | USD 2.91 | 1.87% |
|
China |
|
19 |
USD 1.29 B
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
20 |
USD 1.25 B
|
Dec. 31, 2023 | USD 4.53 | 2.64% |
|
China |
|
21 |
USD 1.21 B
|
Dec. 31, 2023 | USD 5.92 | 1.98% |
|
China |
|
22 |
USD 1.20 B
|
Dec. 31, 2023 | USD 1.46 | 3.48% |
|
China |
|
23 |
USD 1.19 B
|
Dec. 31, 2023 | USD 1.71 | 1.65% |
|
China |
|
24 |
USD 1.18 B
|
Dec. 31, 2023 | USD 0.84 | 6.22% |
|
China |
|
25 |
USD 904.23 M
|
Dec. 31, 2023 | USD 1.40 | 3.01% |
|
China |
|
26 |
USD 871.08 M
|
Dec. 31, 2023 | USD 2.26 | 4.12% |
|
China |
|
27 |
USD 864.10 M
|
Dec. 31, 2023 | USD 6.04 | 3.46% |
|
China |
|
28 |
USD 862.02 M
|
Dec. 31, 2023 | USD 3.86 | 1.55% |
|
China |
|
29 |
USD 832.88 M
|
Dec. 31, 2023 | USD 2.05 | 4.96% |
|
China |
|
30 |
USD 799.05 M
|
Dec. 31, 2023 | USD 1.10 | 2.94% |
|
China |
|
31 |
USD 760.50 M
|
Dec. 31, 2023 | USD 3.54 | 2.01% |
|
China |
|
32 |
USD 698.70 M
|
Dec. 31, 2023 | USD 0.52 | 4.12% |
|
China |
|
33 |
USD 652.72 M
|
Dec. 31, 2023 | USD 1.47 | 0.94% |
|
China |
|
34 |
USD 627.66 M
|
Dec. 31, 2023 | USD 0.99 | 4.49% |
|
China |
|
35 |
USD 594.67 M
|
Dec. 31, 2023 | USD 0.38 | 3.33% |
|
China |
|
36 |
USD 548.78 M
|
Dec. 31, 2023 | USD 1.34 | 1.74% |
|
China |
|
37 |
USD 529.81 M
|
Dec. 31, 2023 | USD 32.18 | 1.97% |
|
China |
|
38 |
USD 510.63 M
|
Dec. 31, 2023 | USD 3.72 | 2.09% |
|
China |
|
39 |
USD 503.54 M
|
Dec. 31, 2023 | USD 3.31 | 1.16% |
|
China |
|
40 |
USD 499.32 M
|
Dec. 31, 2023 | USD 7.41 | 1.09% |
|
China |
|
41 |
USD 493.99 M
|
Dec. 31, 2023 | USD 0.85 | 1.48% |
|
China |
|
42 |
USD 471.94 M
|
Dec. 31, 2023 | USD 12.91 | 2.15% |
|
China |
|
43 |
USD 452.73 M
|
Dec. 31, 2023 | USD 2.14 | 2.31% |
|
China |
|
44 |
USD 436.72 M
|
Dec. 31, 2023 | USD 1.59 | 4.31% |
|
China |
|
45 |
USD 428.06 M
|
Dec. 31, 2023 | USD 0.51 | 3.91% |
|
China |
|
46 |
USD 427.69 M
|
Dec. 31, 2023 | USD 0.53 | 1.04% |
|
China |
|
47 |
USD 422.41 M
|
Dec. 31, 2023 | USD 9.47 | 1.45% |
|
China |
|
48 |
USD 412.84 M
|
Dec. 31, 2023 | USD 2.97 | 0.01% |
|
China |
|
49 |
USD 407.72 M
|
Dec. 31, 2023 | USD 2.16 | 1.67% |
|
China |
|
50 |
USD 397.09 M
|
Dec. 31, 2023 | USD 2.09 | 2.89% |
|
China |
The Pharmaceuticals company in China with the highest Receivables is Sinopharm Group Co. Ltd. (HKSE: 1099.HK) at USD 25.08 B.
The Pharmaceuticals company in China with the lowest Receivables is Zhongzhu Healthcare Holding Co.,Ltd (Shanghai Stock Exchange: 600568.SS) at USD -2.34 M.
The top 10 Pharmaceuticals companies in China by Receivables are Sinopharm Group Co. Ltd., Shanghai Pharmaceuticals Holding Co., Ltd, Fosun International Limited, C.Q. Pharmaceutical Holding Co., Ltd., Jointown Pharmaceutical Group Co., Ltd, Chongqing Zhifei Biological Products Co., Ltd., China National Accord Medicines Corporation Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Shenzhen Neptunus Bioengineering Co., Ltd. and China Meheco Group Co., Ltd..
The bottom 10 Pharmaceuticals companies in China by Receivables are Zhongzhu Healthcare Holding Co.,Ltd, Guangdong Lifestrong Pharmacy Co., Ltd., Shandong Weigao Group Medical Polymer Company Limited, Essex Bio-Technology Limited, Hubei Biocause Pharmaceutical Co., Ltd., Caina Technology Co., Ltd., Mabwell (Shanghai) Bioscience Co., Ltd., Guizhou Yibai Pharmaceutical Co., Ltd., AK Medical Holdings Limited and Shenzhen Bioeasy Biotechnology Co., Ltd..